Drugs.com Medication Guide is a leading medical reference app providing peer-reviewed data on 24,000+ medications for 25 million monthly U.S. visitors. It bridges the gap between professional clinical data and consumer utility through its Pill Identifier and Price Guide. While it maintains high ratings, it is currently navigating a risky transition toward a more aggressive subscription-based monetization model.
Product velocity
Maintenance
Daily rank 🇺🇸
#139
▼9Medical · free
Sentiment
4.8
50k reviews
Nemesis
Fragmented field
The App DNA
What makes this app unique?
For Patients, caregivers, and healthcare professionals seeking reliable, peer-reviewed medication information and management tools.
Key features
Searchable database of over 14,000 medications by imprint, color, and shape.
Locates lowest medication prices and nearby pharmacies to assist with cost management.
Access to FDA monographs and clinical data tailored for healthcare professionals.
Personalized health profile to track medications and interactions with offline access.
How much does it cost?
The app is shifting from a primarily ad-supported model to a high-priced subscription ($8.99/mo), which has triggered a sharp decline in user sentiment and 'greedy' brand associations.
Velocity
Maintenance developmentUX improvementsperformanceShow more...
The app maintains a consistent update cadence of approximately one minor release per month. Development is currently focused on stability and UX polish, including notification service improvements and dark theme tweaks. Without any major feature drops in the observed data, the app appears to be in a stable maintenance phase.
Who built it?
User Sentiment
What do users think recently?
Recent user voice shows an excited sentiment. Users appreciate medication management & information and pill identification, but report monetization & pricing.
How are ratings & reviews evolving?
What users say, by theme
- Medication Management & Information
- Pill Identification
Unlock 1 more frustration theme, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Drugs.com Medication Guide
How's the Medical market?
The rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Drugs.com Medication Guide
Where is it heading?
- Frustrated user base regarding the $8.99/mo subscription shift — high risk of churn to free competitors.
- Technical regressions in v3.1.51 (Mar 2026) causing login failures and UI bugs.
- Active feature investment in UI customization and dark mode (Mar 2026) shows the app is not in maintenance mode.
The SWOT
- Massive database of 24,000+ peer-reviewed medications
- Highly-rated visual Pill Identifier tool
- Strong consumer brand trust (25M monthly visitors)
- Integrated pharmacy discount/pricing tools
- Implement AI image search for pill identification to match PillEye
- Develop robust offline mode for users in low-connectivity areas
- Introduce tiered pricing to mitigate 'all-or-nothing' subscription backlash
Next best moves
Re-evaluate 'Plus Plan' pricing and feature gating.
+ 2 more prioritized movesFeature gaps
AI-powered camera scanning (available in PillEye) +3
Bottom line
Drugs.com is a consumer powerhouse currently jeopardizing its user loyalty through an aggressive and poorly received monetization pivot. While its core utility in pill identification and interaction checking remains a major strength, the PM must urgently address the $8.99/mo price friction and technical stability issues to prevent a mass exodus to free alternatives like Medscape.
Unlock 3 critical frictions, 3 market threats, 2 more prioritized moves and the analyst’s take.
Access the full report for freeReport last updated